Human placental lactogen and color Doppler in predicting expulsion of retained adherent placenta: A new clinical observation

Archives of Gynecology and Obstetrics

Volumn 280, Issue 6, 2009, Pages 1041-1044

  Zepiridis, L ^a   Zafrakas, M ^a   Theodoridis, T D ^a   Assimakopoulos, E ^a   Tzevelekis, P ^a   Athanatos, D ^a   Bontis, J N ^a   Tarlatzis, B C ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Adherent placenta; Color Doppler imaging; Human placental lactogen; Invasive placenta; Retained placenta

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; FOLINIC ACID; HUMAN PLACENTA LACTOGEN; LOW MOLECULAR WEIGHT HEPARIN; METHOTREXATE; METRONIDAZOLE; NETILMICIN; OXYTOCIN; RHESUS D ANTIBODY;

ADULT; ARTICLE; BLEEDING; CASE REPORT; COLOR ULTRASOUND FLOWMETRY; FEMALE; HUMAN; LABOR COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PLACENTA ACCRETA; PLACENTA INCRETA; PLACENTA PERFUSION; RHESUS INCOMPATIBILITY; THROMBOSIS; TRANSVAGINAL ECHOGRAPHY; UTERUS BLEEDING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ADULT; FEMALE; HUMANS; INFANT, NEWBORN; MALE; METHOTREXATE; PLACENTA ACCRETA; PLACENTA, RETAINED; PLACENTAL LACTOGEN; POSTPARTUM HEMORRHAGE; PREGNANCY; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 70350567742     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-009-1045-9     Document Type: Article

References (10)

1. S Wu M Kocherginsky JU Hibbard 2005 Abnormal placentation: twenty-year analysis Am J Obstet Gynecol 192 1458 1461 10.1016/j.ajog.2004.12.074 10.1016/j.ajog.2004.12.074 15902137
2. TH Hung WY Shau CC Hsieh TH Chiu JJ Hsu TT Hsieh 1999 Risk factors for placenta accreta Obstet Gynecol 93 545 550 10.1016/S0029-7844(98)00460-8 10.1016/S0029-7844(98)00460-8 1:STN:280:DyaK1M3ivFKntg%3D%3D 10214831 (Pubitemid 29147074)
3. S Timmermans AC van Hof JJ Duvekot 2007 Conservative management of abnormally invasive placentation Obstet Gynecol Surv 62 529 539 10.1097/01.ogx.0000271133.27011.05 10.1097/01.ogx.0000271133.27011.05 17634154 (Pubitemid 47203383)
4. S Arulkumaran CS Ng I Ingemarsson SS Ratnam 1986 Medical treatment of placenta accreta with methotrexate Acta Obstet Gynecol Scand 65 285 286 1:STN:280:DyaL283pt1WjtQ%3D%3D 3739639
5. YN Bakri A Rifai J Legarth 1993 Placenta praevia-accreta: magnetic resonance imaging findings and methotrexate therapy after hysterectomy Am J Obstet Gynecol 169 213 214 1:STN:280:DyaK3szisFKisA%3D%3D 8333459
6. RS Legro FV Price LM Hill SN Caritis 1994 Nonsurgical management of placenta percreta: a case report Obstet Gynecol 83 847 849 1:STN:280: DyaK2c3htFCnsQ%3D%3D 8159372
7. SJ Dunstone CB Leibowitz 1998 Conservative management of placenta praevia with a high risk of placenta accreta Aust N Z J Obstet Gynaecol 38 429 433 10.1111/j.1479-828X.1998.tb03104.x 10.1111/j.1479-828X.1998.tb03104.x 1:STN:280:DyaK1M7gsFagsA%3D%3D 9890226
8. GM Mussalli J Shah DJ Berck A Elimian N Tejani FA Manning 2000 Placenta accreta and methotrexate therapy: three case reports J Perinatol 20 331 334 10.1038/sj.jp.7200373 10.1038/sj.jp.7200373 1:STN:280:DC%2BD3M%2FktFGgsw%3D%3D 10920795
9. TA Panoskaltsis A Ascarelli N De Souza CD Sims KD Edmonds 2000 Placenta increta: evaluation of radiological investigations and their therapeutic options of conservative management Br J Obstet Gynaecol 107 802 806 1:STN:280:DC%2BD3czgtlymsQ%3D%3D
10. SR Adair D Elamin S Tharmaratnam 2004 Placenta increta: conservative management-a successful outcome. Case report and literature review J Matern Fetal Neonatal Med 15 275 278 10.1080/14767050410001668699 10.1080/ 14767050410001668699 1:STN:280:DC%2BD2cznvFKlsA%3D%3D 15280137 (Pubitemid 38686018)